Parsabiv

(etelcalcetide)

Uses, side effects, dosage information & price range

Amgen Europe B.V.

About this medicine

Parsabiv is indicated for the treatment of secondary hyperparathyroidism (SHPT) in adult patients with chronic kidney disease (CKD) on haemodialysis therapy.

Key Information

Salt / Composition

etelcalcetide

Category

Calcium homeostasis;Anti-parathyroid agents

Manufacturer

Amgen Europe B.V.

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.